$1.66
0.063.75%
At Close: -
$1.70
0.042.41%
After Hours: 7:42 PM EDT
15 minutes delayed
Marinus Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marinus Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.63 | $-0.59 | -6.78 % |
Mar 2024 | 2024-05-08 | $-0.68 | $-0.66 | -3.03 % |
Dec 2023 | 2024-03-05 | $-0.74 | $-0.62 | -19.4 % |
Sep 2023 | 2023-11-07 | $-0.61 | $-0.66 | 7.58 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $8.06M | $9.49M | -15.1 % |
Mar 2024 | 2024-05-08 | $7.68M | $9.12M | -15.8 % |
Dec 2023 | 2024-03-05 | $7.19M | $8.01M | -10.2 % |
Sep 2023 | 2023-11-07 | $7.34M | $6.33M | 15.9 % |
Marinus Pharma (MRNS) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.63, which missed the estimate of $-0.59.
The Actual Revenue was $8.1M, which missed the estimate of $9.5M.
Browse earnings estimates, EPS, and revenue on all stocks.